Compare McKesson Corp. with Similar Stocks
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-2.34%
0%
-2.34%
6 Months
15.62%
0%
15.62%
1 Year
36.25%
0%
36.25%
2 Years
62.95%
0%
62.95%
3 Years
126.71%
0%
126.71%
4 Years
209.53%
0%
209.53%
5 Years
341.77%
0%
341.77%
McKesson Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
10.33%
EBIT Growth (5y)
6.51%
EBIT to Interest (avg)
16.14
Debt to EBITDA (avg)
0.25
Net Debt to Equity (avg)
0.10
Sales to Capital Employed (avg)
76.52
Tax Ratio
20.14%
Dividend Payout Ratio
10.69%
Pledged Shares
0
Institutional Holding
91.44%
ROCE (avg)
377.27%
ROE (avg)
72.81%
Valuation key factors
Factor
Value
P/E Ratio
56
Industry P/E
Price to Book Value
-84.94
EV to EBIT
42.61
EV to EBITDA
36.93
EV to Capital Employed
-77.14
EV to Sales
0.49
PEG Ratio
16.19
Dividend Yield
21.75%
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 187 Schemes (31.84%)
Foreign Institutions
Held by 492 Foreign Institutions (23.88%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
Jun'25
Jun'24
Change(%)
Net Sales
97,827.00
79,283.00
23.39%
Operating Profit (PBDIT) excl Other Income
1,232.00
1,230.00
0.16%
Interest
49.00
66.00
-25.76%
Exceptional Items
-39.00
-41.00
4.88%
Consolidate Net Profit
831.00
960.00
-13.44%
Operating Profit Margin (Excl OI)
11.00%
13.40%
-0.24%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2025 is 23.39% vs 6.44% in Jun 2024
Consolidated Net Profit
YoY Growth in quarter ended Jun 2025 is -13.44% vs -3.71% in Jun 2024
Annual Results Snapshot (Consolidated) - Mar'25
Mar'25
Mar'24
Change(%)
Net Sales
359,051.00
308,951.00
16.22%
Operating Profit (PBDIT) excl Other Income
5,008.00
4,562.00
9.78%
Interest
256.00
243.00
5.35%
Exceptional Items
99.00
-51.00
294.12%
Consolidate Net Profit
3,481.00
3,160.00
10.16%
Operating Profit Margin (Excl OI)
12.20%
12.70%
-0.05%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2025 is 16.22% vs 11.65% in Mar 2024
Consolidated Net Profit
YoY Growth in year ended Mar 2025 is 10.16% vs -15.17% in Mar 2024
About McKesson Corp. 
McKesson Corp.
Retailing
McKesson Corporation is a healthcare supply chain management solution, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare. It operates through three segments: United States Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions and Medical-Surgical Solutions. The United States Pharmaceutical and Specialty Solutions segment distributes pharmaceutical and other healthcare related products and provides pharmaceutical solutions to life sciences companies. European Pharmaceutical Solutions segment provides distribution and services to wholesale, institutional and retail customers. Medical-Surgical Solutions segment distributes medical-surgical supplies and provides logistics and other services to healthcare providers.
Company Coordinates 
Company Details
6555 State Highway 161 , IRVING TX : 75039-2402
Registrar Details






